Matica Fintec Strengthens Global Banking and Payment Ecosystem With Acquisition of Panini
3.9.2025 15:15:00 CEST | Business Wire | Press Release
Matica Fintec S.p.A., a world-leading manufacturer and provider of technology solutions for Financial and Government Institutions, has announced the acquisition of Panini S.p.A., a global leader in check scanning and document digitization technologies previously owned by SETA Holding.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903411079/en/
Matica Fintec S.p.A., has announced the acquisition of Panini S.p.A., a global leader in check scanning and document digitization technologies previously owned by SETA Holding.
The acquisition unites two trusted industry players with deep expertise in secure financial transactions, enhancing Matica Fintec’s banking‑infrastructure capabilities and positioning the company for accelerated growth in its core markets. Moreover, Matica’s recent regional investments – including the manufacturing plant in South Carolina and Minnesota software center – will be a precious contribution to Panini Operations’ footprint and products’ development.
“Panini is a first-class company with a strong legacy in bank technology and long-standing relationships with major financial institutions,” commented Sandro Camilleri, CEO of Matica Fintec. “This acquisition perfectly aligns with our strategy to scale in the fintech space, especially in the U.S. market. It strengthens our portfolio and extends our leadership across the Payment and Identity ecosystem.”
Celebrating its 80th anniversary, Panini has a long history of innovation. From its headquarters in Turin, Italy, to North America subsidiary in Ohio, Panini is a trusted partner for financial institutions worldwide, renowned for its advanced imaging technologies and innovation in payment validation and check truncation.
Fabrizio Rescigno, Panini Board Chairman, commented: “Today the Panini company that is joining Matica Fintec is an example of Italian excellence: world market leader in check scanners, it exports more than 95% of its products to top international banking institutions and invests in R&D to bring new technologies such as BioCred. Company contribution to the surrounding communities in programs concerning education (with SDA Bocconi), medical research (with Mario Negri Institute) and several hospitals has created a responsible internationally recognized brand. This merger should bring an impressive development for the years to come.”
“Becoming part of the Matica Fintec group is an exciting next step for Panini,” said Richard Kane, CEO of Panini. “We share a commitment to customer success and secure innovation.Matica Fintec’s continuing investments in the U.S. market will provide an immediate impact to Panini’s current resources, support capabilities and customized solution offerings that our direct customers, value added resellers and integrators require in the fast-evolving world of fintech.”
This merger combines complementary capabilities, unlocking synergies that will accelerate innovation and growth, thus creating further value for customers and stakeholders of both companies.
Customers will keep collaborating with their established points of reference, now strengthened by additional expertise and resources from key global hubs, ensuring faster, culturally attuned support wherever they operate.
About Matica Fintec S.p.A.
Matica Fintec S.p.A. is a world-leading fintech company specializing in secure digital payments, identity issuance, and smart card personalization. Headquartered in Galliate (NO), Italy, and publicly listed on Euronext Growth Milan (EGM), the company develops and manufactures hardware and software platforms for both centralized and decentralized issuance, supporting governments, financial institutions, and enterprises worldwide.
As part of Matica Group, the company offers reliable and innovative solutions backed by global experience and presence.
About Panini S.p.A.
Founded in Turin, Italy, Panini empower its customers to securely manage high-value information and prevent fraud with its innovative solutions. Panini offers check capture solutions that enable customers to fully realize the advantages and efficiencies available with the digital transformation of paper check, resulting in the world’s largest deployed base of check capture systems. Leveraging its expertise, Panini developed BioCred, its own patented biometric method, to deliver a complete secure identity solution.
Panini continues to expand its portfolio to offer strong, reliable security and a smooth experience for users and customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250903411079/en/
Contacts
communications@maticagroup.com
+39 0321 182 86 01
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom